Kai Ding
Beijing Institute of Technology(CN)Johns Hopkins University(US)University of Pittsburgh(US)Kunming Medical University(CN)Nanjing General Hospital of Nanjing Military Command(CN)Magee-Womens Research Institute(US)First Affiliated Hospital of Kunming Medical University(CN)Cancer Research Center(US)UPMC Hillman Cancer Center(US)Oklahoma State University Oklahoma City(US)OU Health Stephenson Cancer CenterUniversity of Oklahoma Health Sciences Center(US)University of Oklahoma(US)Nanjing University(CN)
Publications by Year
Research Areas
Ovarian cancer diagnosis and treatment, Cancer Genomics and Diagnostics, Venous Thromboembolism Diagnosis and Management, Cancer Cells and Metastasis, Drug Transport and Resistance Mechanisms
Most-Cited Works
- → MICU1 drives glycolysis and chemoresistance in ovarian cancer(2017)170 cited
- → Gut Microbiome and Osteoporosis(2020)120 cited
- → ZIP4 Promotes Pancreatic Cancer Progression by Repressing ZO-1 and Claudin-1 through a ZEB1-Dependent Transcriptional Mechanism(2018)113 cited
- → Regulation of Organic Anion Transporting Polypeptides (OATP) 1B1- and OATP1B3-Mediated Transport: An Updated Review in the Context of OATP-Mediated Drug-Drug Interactions(2018)106 cited
- → Circular RNA HIPK3 promotes gallbladder cancer cell growth by sponging microRNA-124(2018)101 cited
- → ESR1 mutant breast cancers show elevated basal cytokeratins and immune activation(2022)70 cited